Browse
related articles
Lifestyle illnesses boost Hikma sales
- Jordan: Sunday, August 30 - 2009 at 10:29
Jordan-based Hikma Pharmaceuticals has said that sales of drugs to treat lifestyle-related chronic diseases now account for more than half of its sales in the Middle East, where it makes more than two-thirds of its annual turnover, the Financial Times has reported. Increasingly westernised lifestyles amongst people in the Middle East have led to rising sales of hypertension and diabetes drugs, Said Darwazah, Hikma's chief executive said. "Countries such as the UAE, Bahrain and the Gulf countries are having serious problems with diabetes, so we are launching a big portfolio of anti-diabetic products."
Also consider reading:
Today's top stories
Week's top stories
Digg
Facebook
LinkedIn
Twitter
Browse
related articles
StaffSunday, August 30 - 2009 at 10:29 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Disclaimer:
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AMEinfo.com Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AMEinfo.com Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AMEinfo.com Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AMEinfo.com Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
It looks like you are using a Mac - check out our 
Web Feeds